Skip to main content
SpringerLink
Log in

ASO Author Reflections: Predictors of Fiscal Outcomes in CRS-HIPEC and Opportunities for Improvement

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233–80.

    CAS  PubMed  Google Scholar 

  2. Naffouje SA, O’Donoghue C, Salti GI. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: a cost-utility analysis of a hospital’s initial experience and reflections on the health care system. J Surg Oncol. 2016;113:544–7. https://doi.org/10.1002/jso.24162.

    Article  PubMed  Google Scholar 

  3. Squires MH, Staley CA, Knechtle W, et al. Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications. Ann Surg Oncol. 2015;22:1739–45. https://doi.org/10.1245/s10434-014-4025-7.

    Article  PubMed  Google Scholar 

  4. Schwartz PB, Stahl C, Vande Walle K, et al. What drives high cytoreductive surgery and HIPEC costs: patient, provider, or tumor? Ann Surg Oncol. 2020;27:S117.

    Article  Google Scholar 

  5. Webb C, Day R, Velazco CS, et al. Implementation of an enhanced recovery after surgery (ERAS) program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27:303–12. https://doi.org/10.1245/s10434-019-07900-z.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award No. T32 ES007015. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Patrick B. Schwartz MD & Daniel E. Abbott MD

Authors
  1. Patrick B. Schwartz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel E. Abbott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel E. Abbott MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwartz, P.B., Abbott, D.E. ASO Author Reflections: Predictors of Fiscal Outcomes in CRS-HIPEC and Opportunities for Improvement. Ann Surg Oncol 27, 4929–4930 (2020). https://doi.org/10.1245/s10434-020-08598-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08598-0

Search

Navigation